FDA approves diagnostic kit for rare tumor detection

With headquarter in France, Advanced Accelerator Applications S.A. (“AAA” or “the Company”) announced that the US Food and Drug Administration (FDA) has approved NETSPOT (Somakit-TATE) for the localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients. NETSPOT received approval following a Priority Review from the FDA.

NETSPOT is the new … Continue reading

Share

Nestlé and DBV Technologies to develop diagnostic tool for Cow’s Milk Protein Allergy

Nestlé Health Science announced that it has entered into a strategic collaboration with DBV Technologies, headquartered in Montrouge, France, aimed at developing and bringing to market DBV’s innovative patch-test tool for the diagnosis of Cow’s Milk Protein Allergy (CMPA) in infants.

CMPA is a difficult to diagnose condition, which impacts … Continue reading

Share